GSA Capital Partners’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$140K Buy
2025
Q1
Sell
2024
Q4
$727K Buy
2024
Q3
$514K Buy
2024
Q2
$116K Buy
2024
Q1
$158K Buy
2023
Q4
Sell
2023
Q3
$129K Sell
2023
Q2
$1.27M Buy
2023
Q1
$840K Buy
2022
Q4
$189K Sell
2022
Q3
$1.13M Sell
2022
Q2
$780K Buy
2022
Q1
$314K Sell
2021
Q4
$542K Buy
2020
Q3
Sell
2020
Q2
$212K Buy